These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
248 related articles for article (PubMed ID: 18055238)
1. 3D-QSAR CoMFA analysis of C5 substituted pyrrolotriazines as HER2 (ErbB2) inhibitors. Awale M; Mohan CG J Mol Graph Model; 2008 Apr; 26(7):1169-78. PubMed ID: 18055238 [TBL] [Abstract][Full Text] [Related]
2. Novel C-5 aminomethyl pyrrolotriazine dual inhibitors of EGFR and HER2 protein tyrosine kinases. Mastalerz H; Chang M; Gavai A; Johnson W; Langley D; Lee FY; Marathe P; Mathur A; Oppenheimer S; Tarrant J; Tokarski JS; Vite GD; Vyas DM; Wong H; Wong TW; Zhang H; Zhang G Bioorg Med Chem Lett; 2007 May; 17(10):2828-33. PubMed ID: 17368025 [TBL] [Abstract][Full Text] [Related]
3. Molecular modeling studies of vascular endothelial growth factor receptor tyrosine kinase inhibitors using QSAR and docking. Du J; Lei B; Qin J; Liu H; Yao X J Mol Graph Model; 2009 Jan; 27(5):642-54. PubMed ID: 19081278 [TBL] [Abstract][Full Text] [Related]
4. Pharmacophore-based 3D-QSAR of HIF-1 inhibitors. Chung JY; Pasha FA; Cho SJ; Won M; Lee JJ; Lee K Arch Pharm Res; 2009 Mar; 32(3):317-23. PubMed ID: 19387572 [TBL] [Abstract][Full Text] [Related]
6. Receptor-based 3D-QSAR studies of checkpoint Wee1 kinase inhibitors. Wichapong K; Lindner M; Pianwanit S; Kokpol S; Sippl W Eur J Med Chem; 2009 Apr; 44(4):1383-95. PubMed ID: 18976834 [TBL] [Abstract][Full Text] [Related]
7. Exploring the P2 and P3 ligand binding features for hepatitis C virus NS3 protease using some 3D QSAR techniques. Wei HY; Lu CS; Lin TH J Mol Graph Model; 2008 Apr; 26(7):1131-44. PubMed ID: 18024210 [TBL] [Abstract][Full Text] [Related]
8. New C-5 substituted pyrrolotriazine dual inhibitors of EGFR and HER2 protein tyrosine kinases. Mastalerz H; Chang M; Chen P; Dextraze P; Fink BE; Gavai A; Goyal B; Han WC; Johnson W; Langley D; Lee FY; Marathe P; Mathur A; Oppenheimer S; Ruediger E; Tarrant J; Tokarski JS; Vite GD; Vyas DM; Wong H; Wong TW; Zhang H; Zhang G Bioorg Med Chem Lett; 2007 Apr; 17(7):2036-42. PubMed ID: 17270437 [TBL] [Abstract][Full Text] [Related]
9. Novel pyrrolo[2,1-f][1,2,4]triazin-4-amines: Dual inhibitors of EGFR and HER2 protein tyrosine kinases. Fink BE; Norris D; Mastalerz H; Chen P; Goyal B; Zhao Y; Kim SH; Vite GD; Lee FY; Zhang H; Oppenheimer S; Tokarski JS; Wong TW; Gavai AV Bioorg Med Chem Lett; 2011 Jan; 21(2):781-5. PubMed ID: 21177105 [TBL] [Abstract][Full Text] [Related]
10. Design of novel FLT-3 inhibitors based on dual-layer 3D-QSAR model and fragment-based compounds in silico. Shih KC; Lin CY; Chi HC; Hwang CS; Chen TS; Tang CY; Hsiao NW J Chem Inf Model; 2012 Jan; 52(1):146-55. PubMed ID: 22142286 [TBL] [Abstract][Full Text] [Related]
11. Improvement of multivariate image analysis applied to quantitative structure-activity relationship (QSAR) analysis by using wavelet-principal component analysis ranking variable selection and least-squares support vector machine regression: QSAR study of checkpoint kinase WEE1 inhibitors. Cormanich RA; Goodarzi M; Freitas MP Chem Biol Drug Des; 2009 Feb; 73(2):244-52. PubMed ID: 19207427 [TBL] [Abstract][Full Text] [Related]
13. 3D QSAR studies on a series of potent and high selective inhibitors for three kinases of RTK family. Cao H; Zhang H; Zheng X; Gao D J Mol Graph Model; 2007 Jul; 26(1):236-45. PubMed ID: 17293140 [TBL] [Abstract][Full Text] [Related]
14. Receptor-guided alignment-based comparative 3D-QSAR studies of benzylidene malonitrile tyrphostins as EGFR and HER-2 kinase inhibitors. Kamath S; Buolamwini JK J Med Chem; 2003 Oct; 46(22):4657-68. PubMed ID: 14561085 [TBL] [Abstract][Full Text] [Related]
15. 5-((4-Aminopiperidin-1-yl)methyl)pyrrolotriazine dual inhibitors of EGFR and HER2 protein tyrosine kinases. Mastalerz H; Chang M; Chen P; Fink BE; Gavai A; Han WC; Johnson W; Langley D; Lee FY; Leavitt K; Marathe P; Norris D; Oppenheimer S; Sleczka B; Tarrant J; Tokarski JS; Vite GD; Vyas DM; Wong H; Wong TW; Zhang H; Zhang G Bioorg Med Chem Lett; 2007 Sep; 17(17):4947-54. PubMed ID: 17606372 [TBL] [Abstract][Full Text] [Related]
16. 3D-QSAR studies of Checkpoint Kinase Weel inhibitors based on molecular docking, CoMFA and CoMSIA. Yi P; Fang X; Qiu M Eur J Med Chem; 2008 May; 43(5):925-38. PubMed ID: 17698256 [TBL] [Abstract][Full Text] [Related]
17. Molecular modeling studies of phenoxypyrimidinyl imidazoles as p38 kinase inhibitors using QSAR and docking. Ravindra GK; Achaiah G; Sastry GN Eur J Med Chem; 2008 Apr; 43(4):830-8. PubMed ID: 17706839 [TBL] [Abstract][Full Text] [Related]
18. Molecular modeling studies of Rho kinase inhibitors using molecular docking and 3D-QSAR analysis. Qin J; Lei B; Xi L; Liu H; Yao X Eur J Med Chem; 2010 Jul; 45(7):2768-76. PubMed ID: 20347188 [TBL] [Abstract][Full Text] [Related]
19. Binding interaction analysis of the active site and its inhibitors for neuraminidase (N1 subtype) of human influenza virus by the integration of molecular docking, FMO calculation and 3D-QSAR CoMFA modeling. Zhang Q; Yang J; Liang K; Feng L; Li S; Wan J; Xu X; Yang G; Liu D; Yang S J Chem Inf Model; 2008 Sep; 48(9):1802-12. PubMed ID: 18707092 [TBL] [Abstract][Full Text] [Related]
20. Combined 3D-QSAR modeling and molecular docking study on indolinone derivatives as inhibitors of 3-phosphoinositide-dependent protein kinase-1. AbdulHameed MD; Hamza A; Liu J; Zhan CG J Chem Inf Model; 2008 Sep; 48(9):1760-72. PubMed ID: 18717540 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]